Restructuring Loss Masks Weak Operational Core; FY27 Guidance Binary on M&A

Q1 profit was flattened by three layers of one-time costs totaling ₹34.91 crore: ₹21.81 crore in divestment transaction costs (the Akkodis deal), ₹13.1 crore in receivable provisioning largely on an aged defense contract, and ₹3.5 crore in hedge unwinding. These are real costs tied to the restructuring, but they obscure true operational performance. Strip them out and the company was barely profitable—normalized PAT of roughly ₹20.2 crore on ₹183 crore revenue, or about 11% net margin. That's not the picture of a restructuring success story.

Guidance reframed as pro-forma. Prior call (Q3 FY26) promised 40-50% EPS growth for both FY26 and FY27, with 20% EBITDA margin target. Q1 FY27 delivered -₹14.8 crore PAT (continuing entity), sharply contradicting that trajectory. Management has not formally withdrawn the guidance, but reframed FY27 as ₹1,377 crore revenue and ₹270 crore EBITDA (~19.6% margin) on a pro-forma basis—heavily weighted toward the aerospace acquisition not yet closed, and assuming 4 M&A closures this fiscal year. This is an implicit downgrade from the prior explicit guidance. Product mix accelerated via divestment. Divested engineering services (₹163 Cr revenue, mature, low-margin) and aerospace services (~₹70-80 Cr annualized). Retaining defense (₹125 Cr at <10% EBITDA margin after provision), XiDA (₹49.5 Cr at 30% margin), and incoming aerospace manufacturing (acquisition pending). Net-net: continuing ops are now more defense and electronics-heavy, less services-dependent—strategically sound, but near-term margin severely compressed from the loss of a cash-generative services business.

The stock fell 2.92% on day 1 post-result, then rebounded 5.08% by day 3—a modest recovery suggesting the market initially balked at the loss but found credibility in the order book narrative after cooling off. At ₹1600.1, the stock is down 27.63% from its all-time high of ₹2211, a significant repricing that reflects skepticism on the prior 40-50% EPS growth guidance. It trades below its SMA50 (₹1645) but above SMA200 (₹1563), suggesting uncertainty rather than conviction in either direction. RSI is neutral at 56.4, volume is rising—institutional interest is picking up as the stock falls, but ownership data shows no major flows: promoter stable at 58.03%, FII steady at 1.45%, DII at 1.97%. The market is cautiously watching; it has repriced for the miss but hasn't yet committed to the restructuring narrative. Akkodis Phase 1 close (Aug 31) and aerospace acquisition close will be the credibility tests.